Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 GBX | 0.00% | -6.25% | -53.12% |
Apr. 26 | Evgen Pharma plc will Change its Ticker to TCF from EVG | CI |
Apr. 26 | Evgen Pharma plc will Change its Name to TheraCryf plc | CI |
Financials (USD)
Sales 2024 * | 486K | Sales 2025 * | - | Capitalization | 4M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | - | EV / Sales 2024 * | 3.74 x |
Net cash position 2024 * | 2.19M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.59
x | P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.58% |
1 week | -6.25% | ||
Current month | -14.29% | ||
1 month | -11.76% | ||
3 months | -55.88% | ||
6 months | -61.54% | ||
Current year | -53.12% |
Managers | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Toni Haenninen
DFI | Director of Finance/CFO | - | 23-09-04 |
Glen Clack
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Susan Foden
CHM | Chairman | 71 | 14-11-20 |
Alan Barge
BRD | Director/Board Member | - | 15-10-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.75 | 0.00% | 472,919 |
24-05-01 | 0.75 | 0.00% | 5,625 |
24-04-30 | 0.75 | -11.76% | 569,081 |
24-04-29 | 0.85 | +6.25% | 276,632 |
24-04-26 | 0.8 | 0.00% | 144,977 |
Delayed Quote London S.E., May 02, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.12% | 4M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- EVG Stock